Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

ALTAltimmune, Inc.

$335M

Q2 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

$729,74134.6% margin

Operating Income

-$507,744-24.0% margin

Net Income

$8M381.0% margin

EPS (Diluted)

$-7.50

QoQ Revenue Growth

+109.9%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$9M

Stock-Based Comp.

$166,799

Balance Sheet

Total Assets

$28M

Total Liabilities

$4M

Stockholders' Equity

$24M

Cash & Equivalents

$23M

← FY 2016 All Quarters Q3 2016 →

ALT Q2 2016 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena